Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE IGF2BP2 [P = 1.3 × 10(-5); OR (95% CI): 1.66 (1.42-1.94)] and PPARγ [P = 0.005; OR (95% CI): 1.41 (1.10-1.80)] were associated with T2DM in the Lebanese, but not Tunisians, while KCNJ11 [P = 8.0 × 10(-4); OR (95% CI): 1.27 (1.09-1.47)] and SLC30A8 [P = 1.6 × 10(-5); OR (95% CI): 1.37 (1.15-1.62)] were associated with T2DM in the Tunisians, but not Lebanese, after adjusting for gender and body mass index. 22749234 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease GWASCAT Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. 30054458 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE To explore the way that population description is used to replicate and/or extend previously reported genetic observations, we examined articles describing the association of the peroxisome proliferator-activated receptor-gamma-gamma Pro12Ala polymorphism with type 2 diabetes mellitus and related phenotypes, published between 1997 and 2005. 20157827 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. 17213274 2007
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease LHGDN A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians. 12829658 2003
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits. 17434720 2007
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE It has been shown that genetic variation in the PPARgamma gene alters body weight control, lipid and insulin homeostasis, and the susceptibility to type 2 diabetes. 12588773 2003
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease LHGDN SNPs in PPARG associate with type 2 diabetes and interact with physical activity. 18091023 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease GWASCAT Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. 22885922 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE The alanine variant of the Pro12Ala polymorphism of PPARgamma might be associated with decreased risk of DR in T2DM. 18077048 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Like peroxisome proliferator-activated receptor gamma, the SUR1/Kir6.2 gene region both contributes to the inherited risk of type 2 diabetes and encodes proteins that are targets for hypoglycemic medications, providing an intriguing link between the underlying mechanism of disease and validated targets for pharmacological treatment. 15111507 2004
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease GWASCAT Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. 31118516 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Effect of the PPARG2 Pro12Ala Polymorphism on Associations of Physical Activity and Sedentary Time with Markers of Insulin Sensitivity in Those with an Elevated Risk of Type 2 Diabetes. 25974167 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Haplotype comparison analysis indicated that CTTCGGG and CTCTGGG haplotypes with the order of PPARG rs1801282 C>G, PPARG rs3856806 C>T, PPARGC1A rs8192678 C>T, PPARGC1A rs2970847 C>T, PPARGC1A rs3736265 G>A, PPARGC1B rs7732671 G>C and PPARGC1B rs17572019 G>A polymorphisms in gene position significantly increased the risk of T2DM. 28418876 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE In obese subjects, associations with T2D were detected with PPARG Pro12Ala (OR = 0.73, P = 0.004), ADIPOQ -11,377C>G (OR = 1.26, P = 0.02), ENPP1 K121Q (OR = 1.30, P = 0.003) and TCF7L2 rs7903146 (OR = 1.30, P = 1.1 x 10-4), and non-significant associations with HNF1A I27L (OR = 0.96, P = 0.53), GCK -30G>A (OR = 1.15, P = 0.12) and SLC30A8 R325W (OR = 0.95, P = 0.44). 18498634 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Pioglitazone, a PPAR-γ agonist associated with bone loss and risk of fracture in type 2 diabetes mellitus patients. 28810524 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE To test this hypothesis, three potentially functional SNPs of PPAR-γ and four of RXR-α with a minor allele frequency of ≥ 0.05 in the Chinese Han population were identified from the National Center for Biotechnology Information dbSNPs database to evaluate their association with T2DM. 21284483 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE To examine the association of type 2 diabetes susceptibility loci and visceral fat accumulation, we genotyped 1279 Japanese subjects (556 men and 723 women), who underwent computed tomography for measurements of visceral fat area (VFA) and subcutaneous fat area (SFA) for the following single-nucleotide polymorphisms (SNPs): NOTCH2 rs10923931, THADA rs7578597, PPARG rs1801282, ADAMTS9 rs4607103, IGF2BP2 rs1470579, VEGFA rs9472138, JAZF1 rs864745, CDKN2A/CDKN2B rs564398 and rs10811661, HHEX rs1111875 and rs5015480, TCF7L2 rs7901695, KCNQ1 rs2237892, KCNJ11 rs5215 and rs5219, EXT2 rs1113132, rs11037909, and rs3740878, MTNR1B rs10830963, DCD rs1153188, TSPAN8/LGR5 rs7961581, and FTO rs8050136 and rs9939609. 22377712 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Particularly, gene polymorphisms in ADIPOQ (rs1501299 and rs17300539), LepR (rs1137101 and rs1045895), IRS2 (rs1805092), GRB14 (rs10195252 and rs3923113) and PPARG (rs1801282) have been associated with overweight and obesity in uncontrolled T2DM. 26999420 2016
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Peroxisome proliferator-activated receptor gamma is an important regulator of adiposity in mouse and man, and common variation in the PPARG gene has been associated with birthweight, adult obesity, insulin sensitivity and type 2 diabetes. 16007414 2005
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE These results suggest that the PPARgamma is a thrifty gene and that the Pro12Ala PPARgamma2 polymorphism protects against type 2 diabetes in the Japanese. 10777704 2000
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease LHGDN Thus, our model provides structural insight into the impairment of PPARgamma function in type 2 diabetes mellitus. 15558556 2005
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE We conclude that the Ala12 allele of PPARG2 is associated with higher hepatic GU in obese subjects with T2DM. 19303976 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Seven SNPs in six genes known to increase the risk of T2DM in Caucasians were genotyped by means of TaqMan assays in 235 kidney transplant patients medicated with tacrolimus: rs4402960 and rs1470579 in IGF2BP2; rs1111875 in HHEX; rs10811661 upstream of CDKN2A/B; rs13266634 in SLC30A8; rs1801282 in PPARG; rs5215 in KCNJ11. 22569928 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE The Pro12Ala polymorphism in the gene encoding PPARγ (PPARγ2 gene) influences the risk for type 2 diabetes. 21206011 2010